Article Text

other Versions

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
  1. Rebecca H Haberman1,
  2. Ramin Herati2,
  3. David Simon3,
  4. Marie Samanovic2,
  5. Rebecca B Blank4,
  6. Michael Tuen2,
  7. Sergei Koralov2,
  8. Raja Atreya5,
  9. Koray Tascilar6,
  10. Joseph Allen2,
  11. Rochelle Castillo1,
  12. Amber Cornelius2,
  13. Paula Rackoff2,
  14. Gary Solomon2,
  15. Samrachana Adhikari2,
  16. Natalie Azar2,
  17. Pamela Rosenthal2,
  18. Peter Izmirly2,
  19. Jonathan Samuels7,
  20. Brian Golden2,
  21. Soumya M Reddy2,
  22. Markus Neurath8,
  23. Steven B Abramson9,
  24. Georg Schett5,
  25. Mark Mulligan2,
  26. Jose U Scher2
  1. 1 Rheumatology, New York University School of Medicine, New York, New York, USA
  2. 2 New York University School of Medicine, New York, New York, USA
  3. 3 Department of Internal Medicine 3 - Rheumatology and Immunology, University of Erlangen, Erlangen, Germany
  4. 4 NYU Grossman School of Medicine, New York, New York, USA
  5. 5 Rheumatology, University of Erlangen, Erlangen, Germany
  6. 6 Department of Internal Medicine 3—Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
  7. 7 Medicine, NYULMC Hospital for Joint Diseases, New York, New York, USA
  8. 8 Medicine 1, University of Erlangen, Erlangen, Germany
  9. 9 Rheumatology Research, NYU-Hospital for Joint Diseases, New York, New York, USA
  1. Correspondence to Dr Jose U Scher, New York University School of Medicine, New York, NY 10003, USA; jose.scher{at}nyulangone.org

Statistics from Altmetric.com

Jose U Scher, Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis 2021

This is the author’s accepted manuscript of the article. The typeset PDF will appear online as soon as it is ready and it will replace this version.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.